Implicit persuasion in pharmaceutical marketing: ethical implications for regulators and consumers

药品营销中的隐性说服：对监管机构和消费者的道德影响

• 批准号: DP1094577
• 负责人: Prof Justin Oakley
• 金额: $ 29.84万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-04-12 至 2017-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP1094577
• 关键词: Implicit; persuasion; pharmaceutical; marketing; ethical

The rapid ageing of Australia's population has seen increasing consumption of pharmaceuticals and high rates of hospitalisation to treat adverse effects. Pharmaceutical advertising promotes medication use, yet increasing evidence suggests commercials can alter attitudes outside of awareness. Determining the extent and ethical acceptability of subconscious persuasion in drug marketing will lead to more appropriate regulation of advertising content and enhance the autonomy of consumer medication choice. The study outcomes will address Australia's priority research goals Ageing Well, Ageing Productively and Preventative Healthcare, and further this country's international reputation in Applied Ethics.

澳大利亚人口的迅速老龄化导致药品消费量增加，治疗不良反应的住院率也很高。药品广告促进了药物的使用，但越来越多的证据表明，商业广告可以改变意识之外的态度。确定潜意识说服在药品营销中的程度和伦理可接受性，将导致更适当的监管广告内容，提高消费者的用药选择的自主性。该研究成果将解决澳大利亚的优先研究目标老龄化，老龄化生产力和预防性医疗保健，并进一步提高该国在应用伦理学方面的国际声誉。